GAUCHER REGISTRY

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。列出的机构是 中心，不一定是研究者的机构。 戈谢病登记研究是一项持续的上市后观察性数据库，用于跟踪戈谢病患者常规临床实践的结局。并非登记研究中的所有患者均接受酶替代疗法（ERT）。参与登记研究的所有医生均被视为国际合作戈谢组（ICGG）的成员。 从ICGG医生收集的数据将代表常见临床条件下的戈谢病实践模式。 因此，这项国际合作登记研究收集的数据将提供信息，以更好地描述戈谢病的自然史和进展，以及医生处方ERT的患者的临床反应。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The Gaucher Registry is an ongoing, post-marketing, observational database that tracks outcomes of routine clinical practice for patients with Gaucher disease. Not all patients in the Registry are on Enzyme Replacement Therapy (ERT). All physicians participating in the Registry are considered members of the International Collaborative Gaucher Group (ICGG). Data collected from ICGG physicians will represent Gaucher disease practice patterns under common clinical conditions. Thus, the data collected by this international, collaborative Registry will provide information to better characterize the natural history and progression of Gaucher disease, as well as the clinical responses of patients whose physicians have prescribed ERT.